Big pharma stocks have been popular among investors seeking solid dividends for a long time. And for good reason: Large drugmakers historically have generated such tremendous cash flow and earnings that they have been able to reward …
The third-quarter earnings season is off to a strong start. The results of the companies that have reported numbers show that earnings and revenue growth pace is accelerating from the first two quarters. In particular, revenue growth has …
BMY is a stock I have kept an interest in but never actually bought. Your post encouraged me to consider it again .The share price has been in a tight range for 4 years and gone nowhere really and the operating profit has been pretty static …
Analysts have increased the stock’s price target based on the company’s big year in clinical trial results. Bristol Myers Squibb shares were mostly flat during premarket trading Wednesday. The stock has increased 1.5% in the past year. …
Halozyme Therapeutics Inc (NASDAQ:HALO) stock is set to surge in Thursday’s early deals thanks to a licensing deal with Bristol-Myers Squibb Co (NYSE:BMY) for immuno-oncology medicines. The Nasdaq-quoted firm will bank …
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Bristol-Myers Squibb Company …
Nov 10 (Reuters) - Bristol-myers Squibb Co ::U.S. Food and Drug Administration expands approval of Sprycel (dasatinib) to include treatment of children with Philadelphia chromosome-positive chronic myeloid leukemia in chronic …
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AbbVie (ABBV), Union Pacific (UNP) and Bristol-Myers (BMY). These …
Yahoo!5mon